nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—PKMYT1—brain—autistic disorder	0.00126	0.00315	CbGeAlD
Dasatinib—ZAK—head—autistic disorder	0.00126	0.00314	CbGeAlD
Dasatinib—FYN—telencephalon—autistic disorder	0.00126	0.00314	CbGeAlD
Dasatinib—CSK—digestive system—autistic disorder	0.00125	0.00312	CbGeAlD
Dasatinib—YES1—eye—autistic disorder	0.00124	0.00311	CbGeAlD
Dasatinib—SIK3—central nervous system—autistic disorder	0.00124	0.00309	CbGeAlD
Dasatinib—HCK—digestive system—autistic disorder	0.00123	0.00308	CbGeAlD
Dasatinib—EPHA5—head—autistic disorder	0.00123	0.00308	CbGeAlD
Dasatinib—MAP4K5—telencephalon—autistic disorder	0.00123	0.00307	CbGeAlD
Dasatinib—LYN—head—autistic disorder	0.00122	0.00306	CbGeAlD
Dasatinib—PDGFRA—forebrain—autistic disorder	0.00121	0.00302	CbGeAlD
Dasatinib—SIK3—cerebellum—autistic disorder	0.00121	0.00302	CbGeAlD
Dasatinib—BMPR1B—head—autistic disorder	0.00121	0.00301	CbGeAlD
Dasatinib—MAP3K19—head—autistic disorder	0.00121	0.00301	CbGeAlD
Dasatinib—EPHB2—brain—autistic disorder	0.0012	0.00301	CbGeAlD
Dasatinib—SRC—eye—autistic disorder	0.0012	0.00299	CbGeAlD
Dasatinib—ZAK—nervous system—autistic disorder	0.00119	0.00298	CbGeAlD
Dasatinib—SRC—forebrain—autistic disorder	0.00119	0.00296	CbGeAlD
Dasatinib—TNK2—head—autistic disorder	0.00118	0.00296	CbGeAlD
Dasatinib—SRMS—brain—autistic disorder	0.00118	0.00294	CbGeAlD
Dasatinib—EPHB6—telencephalon—autistic disorder	0.00117	0.00293	CbGeAlD
Dasatinib—EPHA5—nervous system—autistic disorder	0.00117	0.00292	CbGeAlD
Dasatinib—LYN—nervous system—autistic disorder	0.00116	0.0029	CbGeAlD
Dasatinib—RIPK2—digestive system—autistic disorder	0.00116	0.0029	CbGeAlD
Dasatinib—EPHA8—brain—autistic disorder	0.00115	0.00288	CbGeAlD
Dasatinib—ZAK—central nervous system—autistic disorder	0.00115	0.00287	CbGeAlD
Dasatinib—BMPR1B—nervous system—autistic disorder	0.00114	0.00286	CbGeAlD
Dasatinib—MAP3K19—nervous system—autistic disorder	0.00114	0.00286	CbGeAlD
Dasatinib—YES1—telencephalon—autistic disorder	0.00113	0.00283	CbGeAlD
Dasatinib—MAP2K5—brainstem—autistic disorder	0.00113	0.00283	CbGeAlD
Dasatinib—EPHA5—central nervous system—autistic disorder	0.00112	0.00281	CbGeAlD
Dasatinib—ZAK—cerebellum—autistic disorder	0.00112	0.0028	CbGeAlD
Dasatinib—TNK2—nervous system—autistic disorder	0.00112	0.0028	CbGeAlD
Dasatinib—LYN—central nervous system—autistic disorder	0.00112	0.00279	CbGeAlD
Dasatinib—PDGFRA—telencephalon—autistic disorder	0.00111	0.00278	CbGeAlD
Dasatinib—TESK1—head—autistic disorder	0.00111	0.00278	CbGeAlD
Dasatinib—ERBB3—digestive system—autistic disorder	0.00111	0.00277	CbGeAlD
Dasatinib—BMPR1B—central nervous system—autistic disorder	0.0011	0.00275	CbGeAlD
Dasatinib—MAP3K19—central nervous system—autistic disorder	0.0011	0.00275	CbGeAlD
Dasatinib—EPHA5—cerebellum—autistic disorder	0.0011	0.00274	CbGeAlD
Dasatinib—EPHB3—head—autistic disorder	0.00109	0.00273	CbGeAlD
Dasatinib—STK36—head—autistic disorder	0.00109	0.00273	CbGeAlD
Dasatinib—SRC—telencephalon—autistic disorder	0.00109	0.00273	CbGeAlD
Dasatinib—STAT5B—brain—autistic disorder	0.00109	0.00273	CbGeAlD
Dasatinib—TNK2—central nervous system—autistic disorder	0.00108	0.0027	CbGeAlD
Dasatinib—BMPR1B—cerebellum—autistic disorder	0.00108	0.00269	CbGeAlD
Dasatinib—CSF1R—eye—autistic disorder	0.00107	0.00268	CbGeAlD
Dasatinib—CSF1R—forebrain—autistic disorder	0.00107	0.00266	CbGeAlD
Dasatinib—LIMK2—head—autistic disorder	0.00106	0.00264	CbGeAlD
Dasatinib—TNK2—cerebellum—autistic disorder	0.00106	0.00264	CbGeAlD
Dasatinib—TESK1—nervous system—autistic disorder	0.00105	0.00263	CbGeAlD
Dasatinib—EPHB3—nervous system—autistic disorder	0.00104	0.00259	CbGeAlD
Dasatinib—STK36—nervous system—autistic disorder	0.00104	0.00259	CbGeAlD
Dasatinib—MAPK14—digestive system—autistic disorder	0.00103	0.00258	CbGeAlD
Dasatinib—FGR—digestive system—autistic disorder	0.00103	0.00257	CbGeAlD
Dasatinib—STK35—head—autistic disorder	0.00103	0.00256	CbGeAlD
Dasatinib—CSK—head—autistic disorder	0.00102	0.00255	CbGeAlD
Dasatinib—TESK1—central nervous system—autistic disorder	0.00102	0.00254	CbGeAlD
Dasatinib—EPHA3—brain—autistic disorder	0.00101	0.00252	CbGeAlD
Dasatinib—HCK—head—autistic disorder	0.00101	0.00251	CbGeAlD
Dasatinib—MAP2K5—telencephalon—autistic disorder	0.001	0.00251	CbGeAlD
Dasatinib—LIMK2—nervous system—autistic disorder	0.001	0.00251	CbGeAlD
Dasatinib—KIT—brainstem—autistic disorder	0.001	0.0025	CbGeAlD
Dasatinib—STK36—central nervous system—autistic disorder	0.000999	0.0025	CbGeAlD
Dasatinib—EPHB3—central nervous system—autistic disorder	0.000999	0.0025	CbGeAlD
Dasatinib—TESK1—cerebellum—autistic disorder	0.000992	0.00248	CbGeAlD
Dasatinib—SIK3—brain—autistic disorder	0.000981	0.00245	CbGeAlD
Dasatinib—EPHB4—digestive system—autistic disorder	0.000979	0.00245	CbGeAlD
Dasatinib—CSF1R—telencephalon—autistic disorder	0.000979	0.00245	CbGeAlD
Dasatinib—EPHB3—cerebellum—autistic disorder	0.000976	0.00244	CbGeAlD
Dasatinib—STK36—cerebellum—autistic disorder	0.000976	0.00244	CbGeAlD
Dasatinib—JAK2—digestive system—autistic disorder	0.000972	0.00243	CbGeAlD
Dasatinib—STK35—nervous system—autistic disorder	0.000972	0.00243	CbGeAlD
Dasatinib—CSK—nervous system—autistic disorder	0.000966	0.00241	CbGeAlD
Dasatinib—LIMK2—central nervous system—autistic disorder	0.000966	0.00241	CbGeAlD
Dasatinib—EPHA2—digestive system—autistic disorder	0.000961	0.0024	CbGeAlD
Dasatinib—FYN—digestive system—autistic disorder	0.000959	0.0024	CbGeAlD
Dasatinib—HCK—nervous system—autistic disorder	0.000953	0.00238	CbGeAlD
Dasatinib—PDGFRB—eye—autistic disorder	0.000953	0.00238	CbGeAlD
Dasatinib—RIPK2—head—autistic disorder	0.000946	0.00236	CbGeAlD
Dasatinib—LIMK2—cerebellum—autistic disorder	0.000944	0.00236	CbGeAlD
Dasatinib—STK35—central nervous system—autistic disorder	0.000936	0.00234	CbGeAlD
Dasatinib—CSK—central nervous system—autistic disorder	0.00093	0.00232	CbGeAlD
Dasatinib—SIK1—head—autistic disorder	0.000923	0.00231	CbGeAlD
Dasatinib—HCK—central nervous system—autistic disorder	0.000918	0.00229	CbGeAlD
Dasatinib—STK35—cerebellum—autistic disorder	0.000915	0.00229	CbGeAlD
Dasatinib—EPHA4—head—autistic disorder	0.000914	0.00228	CbGeAlD
Dasatinib—ZAK—brain—autistic disorder	0.000912	0.00228	CbGeAlD
Dasatinib—CSK—cerebellum—autistic disorder	0.000909	0.00227	CbGeAlD
Dasatinib—ERBB3—head—autistic disorder	0.000905	0.00226	CbGeAlD
Dasatinib—MAP3K2—head—autistic disorder	0.000896	0.00224	CbGeAlD
Dasatinib—EPHA5—brain—autistic disorder	0.000892	0.00223	CbGeAlD
Dasatinib—ABL2—cerebellum—autistic disorder	0.000892	0.00223	CbGeAlD
Dasatinib—KIT—telencephalon—autistic disorder	0.000889	0.00222	CbGeAlD
Dasatinib—LYN—brain—autistic disorder	0.000887	0.00222	CbGeAlD
Dasatinib—SIK1—nervous system—autistic disorder	0.000875	0.00219	CbGeAlD
Dasatinib—BMPR1B—brain—autistic disorder	0.000874	0.00218	CbGeAlD
Dasatinib—MAP3K19—brain—autistic disorder	0.000874	0.00218	CbGeAlD
Dasatinib—ABL1—brainstem—autistic disorder	0.000872	0.00218	CbGeAlD
Dasatinib—BTK—brain—autistic disorder	0.00087	0.00217	CbGeAlD
Dasatinib—PDGFRB—telencephalon—autistic disorder	0.000869	0.00217	CbGeAlD
Dasatinib—EPHA4—nervous system—autistic disorder	0.000867	0.00217	CbGeAlD
Dasatinib—YES1—digestive system—autistic disorder	0.000866	0.00216	CbGeAlD
Dasatinib—ERBB3—nervous system—autistic disorder	0.000858	0.00214	CbGeAlD
Dasatinib—TNK2—brain—autistic disorder	0.000857	0.00214	CbGeAlD
Dasatinib—MAP3K2—nervous system—autistic disorder	0.00085	0.00212	CbGeAlD
Dasatinib—ABL1—eye—autistic disorder	0.000849	0.00212	CbGeAlD
Dasatinib—PDGFRA—digestive system—autistic disorder	0.000849	0.00212	CbGeAlD
Dasatinib—RIPK2—cerebellum—autistic disorder	0.000844	0.00211	CbGeAlD
Dasatinib—SIK1—central nervous system—autistic disorder	0.000843	0.00211	CbGeAlD
Dasatinib—MAPK14—head—autistic disorder	0.000843	0.00211	CbGeAlD
Dasatinib—FGR—head—autistic disorder	0.000839	0.0021	CbGeAlD
Dasatinib—EPHA4—central nervous system—autistic disorder	0.000834	0.00209	CbGeAlD
Dasatinib—SRC—digestive system—autistic disorder	0.000833	0.00208	CbGeAlD
Dasatinib—ERBB3—central nervous system—autistic disorder	0.000826	0.00206	CbGeAlD
Dasatinib—SIK1—cerebellum—autistic disorder	0.000824	0.00206	CbGeAlD
Dasatinib—MAP3K2—central nervous system—autistic disorder	0.000818	0.00204	CbGeAlD
Dasatinib—EPHA4—cerebellum—autistic disorder	0.000815	0.00204	CbGeAlD
Dasatinib—FMO3—head—autistic disorder	0.000811	0.00203	CbGeAlD
Dasatinib—ERBB3—cerebellum—autistic disorder	0.000807	0.00202	CbGeAlD
Dasatinib—TESK1—brain—autistic disorder	0.000806	0.00201	CbGeAlD
Dasatinib—MAP3K2—cerebellum—autistic disorder	0.0008	0.002	CbGeAlD
Dasatinib—CYP1A1—mouth—autistic disorder	0.000799	0.002	CbGeAlD
Dasatinib—MAPK14—nervous system—autistic disorder	0.000799	0.002	CbGeAlD
Dasatinib—FGR—nervous system—autistic disorder	0.000796	0.00199	CbGeAlD
Dasatinib—JAK2—head—autistic disorder	0.000793	0.00198	CbGeAlD
Dasatinib—STK36—brain—autistic disorder	0.000793	0.00198	CbGeAlD
Dasatinib—EPHB3—brain—autistic disorder	0.000793	0.00198	CbGeAlD
Dasatinib—EPHA2—head—autistic disorder	0.000784	0.00196	CbGeAlD
Dasatinib—FYN—head—autistic disorder	0.000782	0.00196	CbGeAlD
Dasatinib—ABL1—telencephalon—autistic disorder	0.000774	0.00193	CbGeAlD
Dasatinib—MAPK14—central nervous system—autistic disorder	0.000769	0.00192	CbGeAlD
Dasatinib—FMO3—nervous system—autistic disorder	0.000769	0.00192	CbGeAlD
Dasatinib—LIMK2—brain—autistic disorder	0.000767	0.00192	CbGeAlD
Dasatinib—FGR—central nervous system—autistic disorder	0.000766	0.00191	CbGeAlD
Dasatinib—MAP3K3—head—autistic disorder	0.000765	0.00191	CbGeAlD
Dasatinib—MAP4K5—head—autistic disorder	0.000765	0.00191	CbGeAlD
Dasatinib—JAK2—nervous system—autistic disorder	0.000752	0.00188	CbGeAlD
Dasatinib—MAPK14—cerebellum—autistic disorder	0.000752	0.00188	CbGeAlD
Dasatinib—CSF1R—digestive system—autistic disorder	0.000748	0.00187	CbGeAlD
Dasatinib—STK35—brain—autistic disorder	0.000743	0.00186	CbGeAlD
Dasatinib—EPHA2—nervous system—autistic disorder	0.000743	0.00186	CbGeAlD
Dasatinib—FYN—nervous system—autistic disorder	0.000742	0.00185	CbGeAlD
Dasatinib—FMO3—central nervous system—autistic disorder	0.00074	0.00185	CbGeAlD
Dasatinib—CSK—brain—autistic disorder	0.000738	0.00184	CbGeAlD
Dasatinib—EPHB6—head—autistic disorder	0.000731	0.00183	CbGeAlD
Dasatinib—HCK—brain—autistic disorder	0.000729	0.00182	CbGeAlD
Dasatinib—MAP3K3—nervous system—autistic disorder	0.000725	0.00181	CbGeAlD
Dasatinib—MAP4K5—nervous system—autistic disorder	0.000725	0.00181	CbGeAlD
Dasatinib—ABL2—brain—autistic disorder	0.000724	0.00181	CbGeAlD
Dasatinib—JAK2—central nervous system—autistic disorder	0.000724	0.00181	CbGeAlD
Dasatinib—CYP1B1—eye—autistic disorder	0.000719	0.0018	CbGeAlD
Dasatinib—EPHA2—central nervous system—autistic disorder	0.000715	0.00179	CbGeAlD
Dasatinib—FYN—central nervous system—autistic disorder	0.000714	0.00178	CbGeAlD
Dasatinib—EPHB4—cerebellum—autistic disorder	0.000713	0.00178	CbGeAlD
Dasatinib—JAK2—cerebellum—autistic disorder	0.000708	0.00177	CbGeAlD
Dasatinib—YES1—head—autistic disorder	0.000706	0.00176	CbGeAlD
Dasatinib—FYN—cerebellum—autistic disorder	0.000698	0.00174	CbGeAlD
Dasatinib—MAP4K5—central nervous system—autistic disorder	0.000698	0.00174	CbGeAlD
Dasatinib—MAP3K3—central nervous system—autistic disorder	0.000698	0.00174	CbGeAlD
Dasatinib—EPHB6—nervous system—autistic disorder	0.000693	0.00173	CbGeAlD
Dasatinib—PDGFRA—head—autistic disorder	0.000693	0.00173	CbGeAlD
Dasatinib—RIPK2—brain—autistic disorder	0.000685	0.00171	CbGeAlD
Dasatinib—MAP4K5—cerebellum—autistic disorder	0.000682	0.0017	CbGeAlD
Dasatinib—MAP3K3—cerebellum—autistic disorder	0.000682	0.0017	CbGeAlD
Dasatinib—SRC—head—autistic disorder	0.000679	0.0017	CbGeAlD
Dasatinib—KIT—digestive system—autistic disorder	0.000679	0.0017	CbGeAlD
Dasatinib—YES1—nervous system—autistic disorder	0.000669	0.00167	CbGeAlD
Dasatinib—SIK1—brain—autistic disorder	0.000669	0.00167	CbGeAlD
Dasatinib—EPHB6—central nervous system—autistic disorder	0.000667	0.00167	CbGeAlD
Dasatinib—PDGFRB—digestive system—autistic disorder	0.000663	0.00166	CbGeAlD
Dasatinib—EPHA4—brain—autistic disorder	0.000662	0.00166	CbGeAlD
Dasatinib—PDGFRA—nervous system—autistic disorder	0.000657	0.00164	CbGeAlD
Dasatinib—ERBB3—brain—autistic disorder	0.000656	0.00164	CbGeAlD
Dasatinib—CYP1B1—telencephalon—autistic disorder	0.000656	0.00164	CbGeAlD
Dasatinib—EPHB6—cerebellum—autistic disorder	0.000652	0.00163	CbGeAlD
Dasatinib—MAP3K2—brain—autistic disorder	0.00065	0.00162	CbGeAlD
Dasatinib—YES1—central nervous system—autistic disorder	0.000645	0.00161	CbGeAlD
Dasatinib—SRC—nervous system—autistic disorder	0.000644	0.00161	CbGeAlD
Dasatinib—PDGFRA—central nervous system—autistic disorder	0.000632	0.00158	CbGeAlD
Dasatinib—YES1—cerebellum—autistic disorder	0.00063	0.00157	CbGeAlD
Dasatinib—MAP2K5—head—autistic disorder	0.000625	0.00156	CbGeAlD
Dasatinib—SRC—central nervous system—autistic disorder	0.00062	0.00155	CbGeAlD
Dasatinib—PDGFRA—cerebellum—autistic disorder	0.000618	0.00154	CbGeAlD
Dasatinib—MAPK14—brain—autistic disorder	0.000611	0.00153	CbGeAlD
Dasatinib—CSF1R—head—autistic disorder	0.00061	0.00152	CbGeAlD
Dasatinib—FGR—brain—autistic disorder	0.000608	0.00152	CbGeAlD
Dasatinib—SRC—cerebellum—autistic disorder	0.000606	0.00151	CbGeAlD
Dasatinib—MAP2K5—nervous system—autistic disorder	0.000592	0.00148	CbGeAlD
Dasatinib—ABL1—digestive system—autistic disorder	0.000591	0.00148	CbGeAlD
Dasatinib—FMO3—brain—autistic disorder	0.000587	0.00147	CbGeAlD
Dasatinib—EPHB4—brain—autistic disorder	0.000579	0.00145	CbGeAlD
Dasatinib—CSF1R—nervous system—autistic disorder	0.000578	0.00144	CbGeAlD
Dasatinib—JAK2—brain—autistic disorder	0.000575	0.00144	CbGeAlD
Dasatinib—MAP2K5—central nervous system—autistic disorder	0.00057	0.00143	CbGeAlD
Dasatinib—EPHA2—brain—autistic disorder	0.000568	0.00142	CbGeAlD
Dasatinib—FYN—brain—autistic disorder	0.000567	0.00142	CbGeAlD
Dasatinib—MAP2K5—cerebellum—autistic disorder	0.000557	0.00139	CbGeAlD
Dasatinib—CSF1R—central nervous system—autistic disorder	0.000557	0.00139	CbGeAlD
Dasatinib—MAP4K5—brain—autistic disorder	0.000554	0.00138	CbGeAlD
Dasatinib—MAP3K3—brain—autistic disorder	0.000554	0.00138	CbGeAlD
Dasatinib—KIT—head—autistic disorder	0.000554	0.00138	CbGeAlD
Dasatinib—CSF1R—cerebellum—autistic disorder	0.000544	0.00136	CbGeAlD
Dasatinib—PDGFRB—head—autistic disorder	0.000541	0.00135	CbGeAlD
Dasatinib—EPHB6—brain—autistic disorder	0.00053	0.00132	CbGeAlD
Dasatinib—KIT—nervous system—autistic disorder	0.000525	0.00131	CbGeAlD
Dasatinib—PDGFRB—nervous system—autistic disorder	0.000513	0.00128	CbGeAlD
Dasatinib—YES1—brain—autistic disorder	0.000512	0.00128	CbGeAlD
Dasatinib—KIT—central nervous system—autistic disorder	0.000505	0.00126	CbGeAlD
Dasatinib—PDGFRA—brain—autistic disorder	0.000502	0.00125	CbGeAlD
Dasatinib—CYP1B1—digestive system—autistic disorder	0.0005	0.00125	CbGeAlD
Dasatinib—KIT—cerebellum—autistic disorder	0.000494	0.00123	CbGeAlD
Dasatinib—PDGFRB—central nervous system—autistic disorder	0.000494	0.00123	CbGeAlD
Dasatinib—SRC—brain—autistic disorder	0.000492	0.00123	CbGeAlD
Dasatinib—ABCG2—telencephalon—autistic disorder	0.000488	0.00122	CbGeAlD
Dasatinib—PDGFRB—cerebellum—autistic disorder	0.000483	0.00121	CbGeAlD
Dasatinib—ABL1—head—autistic disorder	0.000482	0.0012	CbGeAlD
Dasatinib—ABL1—nervous system—autistic disorder	0.000457	0.00114	CbGeAlD
Dasatinib—MAP2K5—brain—autistic disorder	0.000453	0.00113	CbGeAlD
Dasatinib—CSF1R—brain—autistic disorder	0.000442	0.0011	CbGeAlD
Dasatinib—ABL1—central nervous system—autistic disorder	0.00044	0.0011	CbGeAlD
Dasatinib—ABL1—cerebellum—autistic disorder	0.00043	0.00107	CbGeAlD
Dasatinib—CYP1B1—head—autistic disorder	0.000408	0.00102	CbGeAlD
Dasatinib—KIT—brain—autistic disorder	0.000401	0.001	CbGeAlD
Dasatinib—PDGFRB—brain—autistic disorder	0.000392	0.00098	CbGeAlD
Dasatinib—CYP1B1—nervous system—autistic disorder	0.000387	0.000967	CbGeAlD
Dasatinib—CYP1B1—central nervous system—autistic disorder	0.000373	0.000931	CbGeAlD
Dasatinib—CYP1B1—cerebellum—autistic disorder	0.000364	0.00091	CbGeAlD
Dasatinib—CYP1A2—digestive system—autistic disorder	0.000359	0.000896	CbGeAlD
Dasatinib—CYP1A1—digestive system—autistic disorder	0.000354	0.000884	CbGeAlD
Dasatinib—ABL1—brain—autistic disorder	0.000349	0.000873	CbGeAlD
Dasatinib—CYP3A5—digestive system—autistic disorder	0.000346	0.000865	CbGeAlD
Dasatinib—CYP1B1—brain—autistic disorder	0.000296	0.000739	CbGeAlD
Dasatinib—CYP1A1—head—autistic disorder	0.000289	0.000721	CbGeAlD
Dasatinib—CYP1A1—nervous system—autistic disorder	0.000274	0.000684	CbGeAlD
Dasatinib—ABCG2—cerebellum—autistic disorder	0.000271	0.000678	CbGeAlD
Dasatinib—CYP1A1—central nervous system—autistic disorder	0.000263	0.000658	CbGeAlD
Dasatinib—ABCB1—forebrain—autistic disorder	0.000262	0.000654	CbGeAlD
Dasatinib—CYP3A4—digestive system—autistic disorder	0.00026	0.000649	CbGeAlD
Dasatinib—ABCB1—telencephalon—autistic disorder	0.000241	0.000602	CbGeAlD
Dasatinib—ABCG2—brain—autistic disorder	0.00022	0.000551	CbGeAlD
Dasatinib—CYP1A1—brain—autistic disorder	0.000209	0.000523	CbGeAlD
Dasatinib—CYP3A4—nervous system—autistic disorder	0.000201	0.000502	CbGeAlD
Dasatinib—CYP3A4—central nervous system—autistic disorder	0.000193	0.000483	CbGeAlD
Dasatinib—ABCB1—digestive system—autistic disorder	0.000184	0.000459	CbGeAlD
Dasatinib—ABCB1—head—autistic disorder	0.00015	0.000375	CbGeAlD
Dasatinib—ABCB1—nervous system—autistic disorder	0.000142	0.000355	CbGeAlD
Dasatinib—ABCB1—central nervous system—autistic disorder	0.000137	0.000342	CbGeAlD
Dasatinib—ABCB1—cerebellum—autistic disorder	0.000134	0.000334	CbGeAlD
Dasatinib—ABCB1—brain—autistic disorder	0.000109	0.000271	CbGeAlD
Dasatinib—FYN—Signaling Pathways—POMC—autistic disorder	4.39e-06	7.32e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EGF—autistic disorder	4.39e-06	7.32e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PIK3CG—autistic disorder	4.39e-06	7.31e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APC—autistic disorder	4.39e-06	7.31e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	4.38e-06	7.31e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MAPK1—autistic disorder	4.37e-06	7.29e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—PTEN—autistic disorder	4.36e-06	7.27e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TSC2—autistic disorder	4.35e-06	7.25e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ITGB3—autistic disorder	4.34e-06	7.24e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EGF—autistic disorder	4.34e-06	7.23e-06	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—HRAS—autistic disorder	4.33e-06	7.23e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—MAPK1—autistic disorder	4.31e-06	7.19e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.31e-06	7.19e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAT—autistic disorder	4.3e-06	7.16e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PLA2G4A—autistic disorder	4.29e-06	7.16e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GSTM1—autistic disorder	4.29e-06	7.16e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IGF1—autistic disorder	4.29e-06	7.15e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CACNA1C—autistic disorder	4.27e-06	7.12e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—LEP—autistic disorder	4.26e-06	7.1e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOE—autistic disorder	4.26e-06	7.1e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—autistic disorder	4.24e-06	7.06e-06	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HRAS—autistic disorder	4.23e-06	7.06e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—autistic disorder	4.23e-06	7.05e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—autistic disorder	4.23e-06	7.05e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—autistic disorder	4.23e-06	7.05e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IGF1—autistic disorder	4.22e-06	7.04e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—SERPINE1—autistic disorder	4.22e-06	7.04e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—autistic disorder	4.22e-06	7.03e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—BCL2—autistic disorder	4.2e-06	7.01e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—HRAS—autistic disorder	4.2e-06	7e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—autistic disorder	4.18e-06	6.97e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—autistic disorder	4.17e-06	6.96e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—autistic disorder	4.17e-06	6.94e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—autistic disorder	4.16e-06	6.94e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	4.16e-06	6.94e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PTEN—autistic disorder	4.16e-06	6.94e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—PTEN—autistic disorder	4.15e-06	6.91e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—RORA—autistic disorder	4.14e-06	6.89e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GPX1—autistic disorder	4.11e-06	6.86e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.11e-06	6.84e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—MAPK1—autistic disorder	4.08e-06	6.81e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SERPINE1—autistic disorder	4.07e-06	6.79e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IGF1—autistic disorder	4.07e-06	6.78e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PLA2G4A—autistic disorder	4.06e-06	6.76e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GSTM1—autistic disorder	4.06e-06	6.76e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—autistic disorder	4.05e-06	6.76e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—autistic disorder	4.02e-06	6.7e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IGF1—autistic disorder	4.02e-06	6.69e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PRKCB—autistic disorder	4.01e-06	6.69e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SERPINE1—autistic disorder	4.01e-06	6.69e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	4e-06	6.67e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—MAPK1—autistic disorder	4e-06	6.66e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—MAPK1—autistic disorder	3.99e-06	6.64e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—autistic disorder	3.95e-06	6.58e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—PTEN—autistic disorder	3.93e-06	6.56e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HRAS—autistic disorder	3.9e-06	6.51e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—MAPK1—autistic disorder	3.9e-06	6.5e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GPX1—autistic disorder	3.89e-06	6.48e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DHFR—autistic disorder	3.88e-06	6.48e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—MAPK1—autistic disorder	3.88e-06	6.47e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOB—autistic disorder	3.88e-06	6.46e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SERPINE1—autistic disorder	3.86e-06	6.44e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MAPK1—autistic disorder	3.85e-06	6.43e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TSC2—autistic disorder	3.85e-06	6.42e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—MAPK1—autistic disorder	3.84e-06	6.4e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APC—autistic disorder	3.84e-06	6.4e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	3.84e-06	6.4e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SERPINE1—autistic disorder	3.81e-06	6.36e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP19A1—autistic disorder	3.81e-06	6.35e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EGF—autistic disorder	3.8e-06	6.33e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—autistic disorder	3.8e-06	6.33e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—autistic disorder	3.77e-06	6.28e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—autistic disorder	3.77e-06	6.28e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—HRAS—autistic disorder	3.75e-06	6.25e-06	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HRAS—autistic disorder	3.75e-06	6.25e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—autistic disorder	3.74e-06	6.23e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—autistic disorder	3.74e-06	6.23e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PTEN—autistic disorder	3.72e-06	6.2e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—autistic disorder	3.71e-06	6.19e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—autistic disorder	3.7e-06	6.17e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—MAPK1—autistic disorder	3.7e-06	6.17e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—autistic disorder	3.69e-06	6.15e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—MAPK1—autistic disorder	3.68e-06	6.13e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—autistic disorder	3.66e-06	6.1e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—MAPK1—autistic disorder	3.65e-06	6.09e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PTEN—autistic disorder	3.63e-06	6.05e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPH2—autistic disorder	3.6e-06	6.01e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—autistic disorder	3.59e-06	5.99e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—autistic disorder	3.59e-06	5.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PRKCB—autistic disorder	3.55e-06	5.92e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HRAS—autistic disorder	3.55e-06	5.92e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—MAPK1—autistic disorder	3.55e-06	5.91e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DPYD—autistic disorder	3.54e-06	5.91e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—COMT—autistic disorder	3.54e-06	5.91e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—autistic disorder	3.53e-06	5.89e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTP1—autistic disorder	3.53e-06	5.88e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PTEN—autistic disorder	3.52e-06	5.86e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOA—autistic disorder	3.52e-06	5.86e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IGF1—autistic disorder	3.52e-06	5.86e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HRAS—autistic disorder	3.51e-06	5.85e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—PTEN—autistic disorder	3.48e-06	5.81e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—HRAS—autistic disorder	3.46e-06	5.77e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAT—autistic disorder	3.43e-06	5.72e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APC—autistic disorder	3.4e-06	5.67e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3CG—autistic disorder	3.4e-06	5.67e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—autistic disorder	3.4e-06	5.67e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MAPK1—autistic disorder	3.38e-06	5.64e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—autistic disorder	3.38e-06	5.63e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—MAPK1—autistic disorder	3.37e-06	5.62e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—autistic disorder	3.37e-06	5.62e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EGF—autistic disorder	3.36e-06	5.6e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—autistic disorder	3.36e-06	5.6e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	3.34e-06	5.57e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—autistic disorder	3.34e-06	5.56e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—autistic disorder	3.32e-06	5.53e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—autistic disorder	3.3e-06	5.5e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	3.3e-06	5.49e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—HRAS—autistic disorder	3.28e-06	5.47e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.27e-06	5.46e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—autistic disorder	3.25e-06	5.41e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	3.24e-06	5.4e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTM1—autistic disorder	3.24e-06	5.4e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTEN—autistic disorder	3.24e-06	5.4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—autistic disorder	3.24e-06	5.4e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTEN—autistic disorder	3.22e-06	5.36e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	3.21e-06	5.35e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—HRAS—autistic disorder	3.21e-06	5.35e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HRAS—autistic disorder	3.2e-06	5.33e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK1—autistic disorder	3.2e-06	5.33e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3CG—autistic disorder	3.19e-06	5.32e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	3.17e-06	5.28e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—autistic disorder	3.14e-06	5.23e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—HRAS—autistic disorder	3.13e-06	5.22e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—autistic disorder	3.13e-06	5.21e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HRAS—autistic disorder	3.12e-06	5.2e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—autistic disorder	3.11e-06	5.19e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GPX1—autistic disorder	3.1e-06	5.17e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PTEN—autistic disorder	3.1e-06	5.17e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HRAS—autistic disorder	3.09e-06	5.16e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—autistic disorder	3.09e-06	5.14e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—HRAS—autistic disorder	3.08e-06	5.14e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—autistic disorder	3.07e-06	5.12e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—autistic disorder	3.07e-06	5.12e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—autistic disorder	3.06e-06	5.1e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PTEN—autistic disorder	3.05e-06	5.09e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP19A1—autistic disorder	3.04e-06	5.07e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—autistic disorder	3.04e-06	5.06e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK1—autistic disorder	3.02e-06	5.04e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CG—autistic disorder	3.01e-06	5.02e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—autistic disorder	3e-06	5e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DHFR—autistic disorder	3e-06	5e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—autistic disorder	2.98e-06	4.97e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HRAS—autistic disorder	2.97e-06	4.95e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—autistic disorder	2.96e-06	4.94e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SERPINE1—autistic disorder	2.96e-06	4.93e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HRAS—autistic disorder	2.95e-06	4.92e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MAPK1—autistic disorder	2.95e-06	4.92e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—autistic disorder	2.95e-06	4.92e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTEN—autistic disorder	2.95e-06	4.91e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PTEN—autistic disorder	2.94e-06	4.9e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HRAS—autistic disorder	2.93e-06	4.89e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PTEN—autistic disorder	2.9e-06	4.84e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—autistic disorder	2.87e-06	4.78e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—autistic disorder	2.86e-06	4.77e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK1—autistic disorder	2.86e-06	4.77e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.86e-06	4.76e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—HRAS—autistic disorder	2.85e-06	4.75e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—autistic disorder	2.84e-06	4.74e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK1—autistic disorder	2.83e-06	4.72e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—COMT—autistic disorder	2.83e-06	4.71e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—autistic disorder	2.83e-06	4.71e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTP1—autistic disorder	2.81e-06	4.69e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOA—autistic disorder	2.81e-06	4.68e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—autistic disorder	2.81e-06	4.68e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAT—autistic disorder	2.74e-06	4.57e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—autistic disorder	2.73e-06	4.54e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HRAS—autistic disorder	2.72e-06	4.53e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—HRAS—autistic disorder	2.71e-06	4.51e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—autistic disorder	2.7e-06	4.51e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—autistic disorder	2.67e-06	4.44e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MAPK1—autistic disorder	2.61e-06	4.36e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—autistic disorder	2.6e-06	4.33e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—autistic disorder	2.59e-06	4.32e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PLA2G4A—autistic disorder	2.59e-06	4.31e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTM1—autistic disorder	2.59e-06	4.31e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	2.58e-06	4.3e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—HRAS—autistic disorder	2.57e-06	4.28e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PTEN—autistic disorder	2.54e-06	4.24e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK1—autistic disorder	2.52e-06	4.21e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK1—autistic disorder	2.48e-06	4.14e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GPX1—autistic disorder	2.48e-06	4.13e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—autistic disorder	2.46e-06	4.1e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HRAS—autistic disorder	2.43e-06	4.04e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—autistic disorder	2.42e-06	4.04e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CG—autistic disorder	2.41e-06	4.01e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—autistic disorder	2.39e-06	3.99e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK1—autistic disorder	2.39e-06	3.99e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—HRAS—autistic disorder	2.37e-06	3.95e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK1—autistic disorder	2.36e-06	3.94e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.35e-06	3.91e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—autistic disorder	2.32e-06	3.87e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HRAS—autistic disorder	2.3e-06	3.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—autistic disorder	2.29e-06	3.82e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—autistic disorder	2.29e-06	3.81e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—autistic disorder	2.29e-06	3.81e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—HRAS—autistic disorder	2.27e-06	3.79e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—autistic disorder	2.27e-06	3.78e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PTEN—autistic disorder	2.25e-06	3.75e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—autistic disorder	2.2e-06	3.66e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—COMT—autistic disorder	2.18e-06	3.64e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—autistic disorder	2.18e-06	3.63e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTP1—autistic disorder	2.17e-06	3.62e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOA—autistic disorder	2.17e-06	3.61e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—autistic disorder	2.13e-06	3.55e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAT—autistic disorder	2.11e-06	3.52e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTEN—autistic disorder	2.11e-06	3.52e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—HRAS—autistic disorder	2.1e-06	3.5e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	2.07e-06	3.45e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK1—autistic disorder	2.07e-06	3.45e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HRAS—autistic disorder	2.03e-06	3.38e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—autistic disorder	2.01e-06	3.35e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	2e-06	3.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTM1—autistic disorder	2e-06	3.33e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTEN—autistic disorder	1.99e-06	3.33e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HRAS—autistic disorder	1.99e-06	3.32e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—autistic disorder	1.98e-06	3.3e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—autistic disorder	1.94e-06	3.23e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CG—autistic disorder	1.92e-06	3.2e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HRAS—autistic disorder	1.92e-06	3.2e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GPX1—autistic disorder	1.91e-06	3.19e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—autistic disorder	1.91e-06	3.18e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HRAS—autistic disorder	1.9e-06	3.16e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—autistic disorder	1.84e-06	3.06e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK1—autistic disorder	1.83e-06	3.05e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—autistic disorder	1.83e-06	3.05e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—autistic disorder	1.83e-06	3.05e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—autistic disorder	1.81e-06	3.02e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—autistic disorder	1.76e-06	2.94e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HRAS—autistic disorder	1.66e-06	2.77e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—autistic disorder	1.64e-06	2.74e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTEN—autistic disorder	1.59e-06	2.66e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—autistic disorder	1.59e-06	2.65e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.48e-06	2.47e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HRAS—autistic disorder	1.47e-06	2.45e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—autistic disorder	1.46e-06	2.43e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—autistic disorder	1.41e-06	2.35e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—autistic disorder	1.41e-06	2.34e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTEN—autistic disorder	1.27e-06	2.12e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—autistic disorder	1.13e-06	1.88e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTEN—autistic disorder	9.82e-07	1.64e-06	CbGpPWpGaD
